» Articles » PMID: 36947360

Relationship Between HuR and Tumor Drug Resistance

Overview
Specialty Oncology
Date 2023 Mar 22
PMID 36947360
Authors
Affiliations
Soon will be listed here.
Abstract

Human resistance protein R (HuR), also known as embryonic lethal abnormal visual-like protein (ELAVL1), is an RNA-binding protein widely expressed in vivo that affects the mRNA stability of targeted and is involved in post-transcriptional regulation. Recent studies have shown that HuR is aberrantly expressed in different human cancers and is an essential factor in poor clinical prognosis. The role of HuR in numerous tumors suggests that it could be a new target for tumor therapy and as a marker for efficacy and prognostic assessment. This review focuses on the relationship between HuR and drug resistance in different tumors and briefly describes the structure, function, and inhibitors of HuR. We summarize the mechanisms by which HuR causes tumor resistance and the molecular targets affected.

Citing Articles

mA-Modified SNRPA Controls Alternative Splicing of ERCC1 Exon 8 to Induce Cisplatin Resistance in Lung Adenocarcinoma.

Fan W, Huang J, Tian F, Hong X, Zhu K, Zhan Y Adv Sci (Weinh). 2024; 11(47):e2404609.

PMID: 39555714 PMC: 11653629. DOI: 10.1002/advs.202404609.


Tackling the HuRdle of radioresistance: a radiation perspective on the RNA-binding protein HuR.

Troschel F, Eich H, Greve B Transl Cancer Res. 2024; 12(12):3223-3226.

PMID: 38192977 PMC: 10774030. DOI: 10.21037/tcr-23-1866.

References
1.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

2.
Kozar I, Margue C, Rothengatter S, Haan C, Kreis S . Many ways to resistance: How melanoma cells evade targeted therapies. Biochim Biophys Acta Rev Cancer. 2019; 1871(2):313-322. DOI: 10.1016/j.bbcan.2019.02.002. View

3.
Seyfried T, Huysentruyt L . On the origin of cancer metastasis. Crit Rev Oncog. 2012; 18(1-2):43-73. PMC: 3597235. DOI: 10.1615/critrevoncog.v18.i1-2.40. View

4.
Gebauer F, Schwarzl T, Valcarcel J, Hentze M . RNA-binding proteins in human genetic disease. Nat Rev Genet. 2020; 22(3):185-198. DOI: 10.1038/s41576-020-00302-y. View

5.
Gerstberger S, Hafner M, Tuschl T . A census of human RNA-binding proteins. Nat Rev Genet. 2014; 15(12):829-45. PMC: 11148870. DOI: 10.1038/nrg3813. View